Can event-related potential predict the progression of mild cognitive impairment?

Journal of Clinical Neurophysiology

Volumn 28, Issue 6, 2011, Pages 625-632

  Bennys, Karim ^a   Rondouin, Gérard ^a   Benattar, Elise ^a   Gabelle, Audrey ^a,b   Touchon, Jacques ^a  

^a MONTPELLIER UNIVERSITY HOSPITAL   (France)

^b INSTITUTE OF HUMAN GENETICS   (France)

Author keywords

aging; Alzheimer's disease; Event related evoked potentials; Mild cognitive impairment

Indexed keywords

ALZHEIMER DISEASE; ARTICLE; CHILD; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE COURSE; EVENT RELATED POTENTIAL; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TEST; PREDICTION; PREDICTIVE VALUE; PRESCHOOL CHILD; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; VERBAL COMMUNICATION;

ACOUSTIC STIMULATION; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; DISEASE PROGRESSION; ELECTRIC STIMULATION; EVOKED POTENTIALS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MENTAL STATUS SCHEDULE; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TESTS; PREDICTIVE VALUE OF TESTS; REACTION TIME; ROC CURVE;

EID: 84855865078     PISSN: 07360258     EISSN: 15371603     Source Type: Journal    
DOI: 10.1097/WNP.0b013e31823cc2d3     Document Type: Article

References (37)

1. Amieva H, Le Goff M, Millet X, et al. Prodromal Alzheimer's disease: successive emergence of the clinical symptoms. Ann Neurol 2008;64:492-498.
2. Baddeley AD, Baddeley HA, Bucks RS, et al. Attentional control in Alzheimer's disease. Brain 2001;124:1479-1481.
3. Bennys K, Portet F, Touchon J, et al. Diagnostic value of event-related evoked potentials N200 and P300 subcomponents in early diagnosis of Alzheimer's disease and mild cognitive impairment. J Clin Neurophysiol 2007;24: 405-412. (Pubitemid 47524880)
4. Beuzeron-Mangina H, Mangina CA. Excessive compensatory recruitment as a compulsory neurophysioloical mechanism in very early Alzheimer's disease as compared to mild vascular dementia and to age-matched normal controls. Int J Psychophysiol 2009;73:164-169.
5. Brookmeyer R, Johnson E, Ziegler-Graham K, et al. Forecasting the global burden of Alzheimer's disease. Alzheimers Dement 2007;3:186-191. (Pubitemid 46825511)
6. Carlson MC, Xue QL, Zhou J, et al. Executive decline and dysfunction precedes declines in memory: the Women's Health and Aging Study II. J Gerontol A Biol Sci Med Sci 2009;64:110-117.
7. Chapman RM, McCrary JW, Gardner MN, et al. Brain ERP components predict which individuals progress to Alzheimer's disease and which do not. Neuro-biol Aging 2011;32:1742-1755.
8. Dubois B. Interest of the new criteria for drug trials in AD. J Nutr Health Aging 2009;13:356-357.
9. Dubois B, Feldman HH, Jacova C, et al. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 2007;6:734-746. (Pubitemid 47058377)
10. Folstein MF, Folstein SE, McHugh PR. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
11. Frodl T, Hampel H, Juckel G, et al. Value of event-related P300 subcomponents in the clinical diagnosis of mild cognitive impairment and Alzheimer's disease. Psychophysiology 2002;39:175-181. (Pubitemid 34263254)
12. Gauthier S, Scheltens P. Can we do better in developing new drugs for Alzheimer's disease? Alzheimer's Dement 2009;5:489-491.
13. Gauthier S, Touchon J. Mild cognitive impairment is not a clinical entity and should not be treated. Arch Neurol 2005;62:1164-1166. (Pubitemid 41043745)
14. Gironell A, García-Sánchez C, Estévez- González A, et al. Usefulness of P300 in subjective memory complaints: a prospective study. J Clin Neurophysiol 2005;22:279-284. (Pubitemid 41161403)
15. Godefroy O, et Le GREFEX MD. Fonctions Executives et Pathologiques Neurologiques et Psychiatriques. Marseille, France Solal, 2008.
16. Golob EJ, Irimajiri R, Starr A. Auditory cortical activity in amnestic mild cognitive impairment: relationship to subtype and conversion to dementia. Brain 2007;130:740-752. (Pubitemid 46410738)
17. Golob EJ, Ringman JM, Irimajiri R, et al. Cortical event-related potentials in preclinical familial Alzheimer disease. Neurology 2009;73:1649-1655.
18. Isaacs B, Akhtar AJ. The set test: a rapid test of mental function in old people. Age Ageing 1972;1:222-226.
19. Jack CR Jr, Shiung MM, Weigand SD, et al. Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI. Neurology 2005;65:1227-1231. (Pubitemid 41508215)
20. Juckel G, Clotz F, Frodl T, et al. Diagnostic usefulness of cognitive auditory event-related p300 subcomponents in patients with Alzheimer's disease. 2008;25:147-152.
21. Kalafat M, Hugonot-Diener L, Poitrenaud J. Etalonnage français du MMS version GRECO. Rev de Neuropsychol 2003;13:209-236.
22. Kirino E, Belger A, Goldman-Rkic P, et al. Prefrontal activation evoked by infrequent target and novel stimuli in a visual target detection task: an event-related functional magnetic resonance study. J Neurosci 2000;20:6612-6618.
23. Knight R. Contribution of human hippocampal region to novelty detection. Nature 1996;383:256-259. (Pubitemid 26317674)
24. Li C, Zheng J, Wang J, et al. An fRMI stroop task study of prefrontal cortical function in normal aging, mild cognitive impairment, and Alzheimer's disease. Curr Alzheimer Res 2009;6:525-530.
25. Missonnier P, Gold G, Fazio-Costa L, et al. Early event-related potential changes during working memory activation predict rapid decline in mild cognitive impairment. J Gerontol A Biol Sci Med Sci 2005;60: 660-666. (Pubitemid 40847936)
26. Murphy C, Cerf-Ducastel B, Calhoun-Haney R, et al. ERP, fMRI and functional connectivity studies of brain response to odor in normal aging and Alzheimer's disease. Chem Senses 2005;30:i170-i171.
27. Papaliagkas V, Kimiskidis V, Tsolaki M, et al. Usefulness of event-related potentials in the assessment of mild cognitive impairment. BMC Neurosci 2008;9:107.
28. Papaliagkas VT, Anogianakis G, Tsolaki MN, et al. Combination of P300 and CSF b-amyloid(1-42) assays may provide a potential tool in the early diagnosis of Alzheimer's disease. Curr Alzheimer Res 2010;7:295-299.
29. Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med 2004;256:183-194. (Pubitemid 39222988)
30. Petersen RC, Smith GE, Waring SC, et al. Mild cognitive Impairment: clinical characterization and outcome. Arch Neurol 1999;56:303-308. (Pubitemid 29120227)
31. Petersen RC, Doody R, Kurz A, et al. Current concepts in mild cognitive impairment. Arch Neurol 2001;58:1985-1992. (Pubitemid 33143977)
32. Polich J. Updating P300: an integrative theory of P3a and P3b. Clin Neurophysiol 2007;118:2128-2148. (Pubitemid 47385341)
33. Polich J, Criado JR. Neuropsychology and neuropharmacology of P3a and P3b. Int J Psychophysiol 2006;60:172-185. (Pubitemid 43776735)
34. Ritchie K, Ledésert B, Touchon J. Subclinical cognitive impairment epidemiology and clinical characteristics. Compr Psychiatry 2000;41:61-65. (Pubitemid 30146636)
35. Van der Linden M, Coyette F, Pointrenaud J, et al. L'évaluation des troubles de la mémoire: Présentation de quatre tests de mémoire épisodique (avec leur étalonnage). Van der Linden M, Adam S, Agniel A, Baisset Mouly C, et al (eds). Marseille, Solal, 2004, pp 25-48.
36. Walhovd KB, Fjell AM. The relationship between P3 and neuropsychological function in an adult life span sample. Biol Psychol 2003;62:65-87. (Pubitemid 36194421)
37. Wechsler D. Echelle Clinique de Mémoire de Wechler MEM-III (WMS-III). Paris, France: Les Editions du Centre de Psychologie Appliquée. 2001.